5 Common Myths About Breast Cancer

A breast cancer diagnosis can bring fear, confusion, and a flood of questions. And during Breast Cancer Awareness Month, it’s not just about raising visibility—it’s about replacing fear with facts and clearing up common misunderstandings that can keep people from getting the care or clarity they need.

This month, more than 22,000 people in the U.S. will receive a breast cancer diagnosis. While it’s the second most commonly diagnosed cancer among American women, it can affect anyone—with or without risk factors, with or without a family history. Let’s take a moment to clear up some of the most common myths.

Myth #1: Breast cancer only affects women.
The truth is, anyone with breast tissue can get breast cancer. While men account for less than 1% of diagnoses in the U.S., that still means more than 2,000 men will be diagnosed this year. Awareness and early detection matter—regardless of gender.


Myth #2: If you have the BRCA gene, you’re more likely to get cancer.
It’s a bit more complicated. Everyone has BRCA1 and BRCA2 genes—they help prevent cancer by repairing cell damage. But some people inherit mutated forms of these genes, which don’t function properly. That mutation increases the likelihood of developing breast cancer over a lifetime—but it doesn’t guarantee it.




Myth #3: If I don’t have a family history, I don’t need to worry.
While family history can raise your risk, the majority of people diagnosed—over 60%—have no known risk factors. Breast cancer can happen to anyone, which is why regular screening and self-awareness are so important.

Myth #4: If I find a lump, it’s probably cancer.
Not necessarily. Breast tissue changes over time due to age, hormones, and other factors. Many lumps are benign—things like cysts or fibroadenomas. In fact, only 3% to 5% of breast lumps turn out to be cancer. Still, any new or unusual lump should be checked by a medical provider to be sure.

Myth #4: If I find a lump, it’s probably cancer.
Not necessarily. Breast tissue changes over time due to age, hormones, and other factors. Many lumps are benign—things like cysts or fibroadenomas. In fact, only 3% to 5% of breast lumps turn out to be cancer. Still, any new or unusual lump should be checked by a medical provider to be sure.


Myth #5: Birth control pills cause breast cancer.
Some types of hormonal birth control are linked to a slight increase in breast cancer risk, particularly for women over 40. But the risk declines after stopping the medication and returns to normal after about 5–10 years. For many, the benefits outweigh the risks—but it’s a personal decision best made with your doctor’s guidance.

You Don’t Have to Sort Through This Alone
At Ardynn, we understand how overwhelming it can be to separate facts from fear—especially after a diagnosis. Our board-certified advocates help people understand their diagnosis, explore their options, and make treatment decisions with confidence and clarity.

We combine advanced data with human support—so every person we work with receives insight that’s specific to their diagnosis, their health, and their life.

If you or someone you love has questions about breast cancer or needs support, we’re here.
To get started with an advocate, contact Ardynn member services at 737-307-0077 or click here to schedule an introductory call. Because no one should have to go through this alone.

Share

Recent Articles

Bridging the Gap Between Data and Humanity in Cancer Care

For health plans, data has become the backbone of smarter cancer care. Real-world evidence (RWE), predictive analytics, treatment pathways—these tools offer unprecedented insight into what works, for whom, and under what circumstances. But for members suddenly facing a cancer diagnosis, data alone isn’t enough. When fear, uncertainty, and information overload

Read More »

The Benefits of Using a Cancer Advocate for Treatment Decisions and Beyond

Navigating a cancer diagnosis can be overwhelming, both for patients and their families. From understanding complex medical information to making critical treatment decisions, the journey through cancer care is fraught with challenges. This is where a cancer advocate can make a significant difference. By providing support, guidance, and expertise, cancer

Read More »

Advancing Health Equity in Cancer Care: Why Trust and Advocacy Matter

Despite major breakthroughs in cancer treatment and early detection, stark disparities in outcomes persist—and for many communities, they’re getting worse, not better. Black Americans, for example, continue to experience the highest cancer death rates of any racial or ethnic group in the U.S. (American Cancer Society, 2024). Hispanic and Native

Read More »

Redefining Cancer Support: Why Whole-Person Advocacy Matters

When a member receives a cancer diagnosis, they embark on one of the most complex, emotional, and high-stakes journeys in healthcare. For health plans, this journey is a critical inflection point—impacting not only cost and quality metrics, but also trust, retention, and overall member satisfaction. Yet traditional support models are

Read More »